Dr. Ufret-Vincenty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-2020Fax+1 214-645-2011
Education & Training
- Cleveland Clinic FoundationFellowship, Surgical Retina and Vitreous, 2004 - 2006
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2001 - 2004
- University of Puerto Rico School of MedicineClass of 2000
Certifications & Licensure
- TX State Medical License 2006 - 2026
- OH State Medical License 2004 - 2007
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Visual Enhancement Device in Low Vision Patients Start of enrollment: 2015 Feb 01
Publications & Presentations
PubMed
- Nonredundant Role of Leishmanolysin-Like (Lmln) Zinc-Metallopeptidase in Retinal Homeostasis.Rafael L Ufret-Vincenty, Dogan Can Kirman, Gizem Ulker-Yilmazer, Bogale Aredo, Sangita Shrestha
American Journal of Ophthalmology. 2025-01-01 - Atypical Central Serous Chorioretinopathy Masquerading as Vogt-Koyanagi-Harada Disease: A Case Report.Munevver Duran, David Shieh, Preston Choi, Yu-Guang He, Rafael L Ufret-Vincenty
Case Reports in Ophthalmology. 2024-05-24 - 2 citationsE3 ubiquitin ligase Herc3 deficiency leads to accumulation of subretinal microglia and retinal neurodegeneration.Yeshumenesh Zegeye, Bogale Aredo, Seher Yuksel, Dogan Can Kirman, Ashwani Kumar
Scientific Reports. 2024-02-06
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: